"Serum Institute"
Latest news and video coverage curated from trusted media outlets
0 shares | ShareTweetSavePostSend |
You Might Like
Karan on selling 50 per cent of Dharma to PoonawallaIn 2024, Karan Johar made headlines when he sold a 50 percent stake of his production company, Dharma Productions, to Serum Institute of India CEO Adar Poonawalla for a staggering Rs 1,000 crore. In a..IndiaTimes - Published | |
SII CEO Adar Poonawalla buys Rs 1.04 crore matte black Land Rover Defender 110 X for...Indian billionaires are known for their luxurious lifestyles, often accompanied by an impressive fleet of vehicles and security cars. Adar Poonawalla, CEO of Serum Institute of India, is no exception.DNA - Published | |
After Anand Mahindra, Adar Poonawalla responds to L&T chief's 90-hour work week remark: 'My wife loves staring at me'Adar Poonawalla, CEO of the Serum Institute of India, backed Mahindra Group Chairman Anand Mahindra's call for prioritising quality over quantity in work hoursDNA - Published | |
Karan posts cryptic message after Jaaved mocks dealKaran Johar recently made waves in the industry by selling a 50 per cent stake in Dharma Productions to Adar Poonawalla, CEO of Serum Institute. Though the reason behind Johar’s search for an..IndiaTimes - Published | |
Meet Pune's richest man who owns Rs 750 crore home, has net worth of over Rs 204300 crore, he is...This is one of India's richest man who built the Serum Institute into the world's largest vaccine producer amassing a fortune of Rs 2,89,900 crore.DNA - Published | |
Supreme Court bins pleas for probe into Covid jab side-effectsThe Supreme Court dismissed a PIL seeking an investigation into alleged side effects of the Covishield vaccine, developed by AstraZeneca and Oxford and produced by Serum Institute of India. The..IndiaTimes - Published | |
Serum Institute of India (SII) working on vaccine for Mpox outbreak: CEO Adar PoonawallaFollowing the state government's guidelines on Mpox response, Serum Institute of India (SII) CEO Adar Poonawalla announced ongoing efforts to develop a vaccine, expecting positive results within a..IndiaTimes - Published | |
Meet Indian, who owns over Rs 1400 crore mansion in London, much costlier than Mukesh Ambani, Lakshmi Mittal's UK homesSerum Life Sciences, a UK-based subsidiary of the Poonawalla family's Serum Institute of India, will acquire the property, the reported quoted people familiar with the transaction as saying.DNA - Published | |
Serum to buy 20% in med tech firmSerum Institute of India (SII) invested in IntegriMedical, a med tech firm, for needle-free injection system tech. The partnership aims to provide 'health for all' and 'transform healthcare globally'..IndiaTimes - Published | |
WHO approves Japan-made dengue vaccineWHO approves TAK-003 (Qdenga) as 2nd dengue vaccine for children aged 6-16 in high-burden areas. Takeda in talks to launch in India. Panacea Biotec & Serum Institute collaborate on indigenous vaccine..IndiaTimes - Published | |
1 in 3 Covaxin recipients hit by adverse events: StudyNearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..IndiaTimes - Published | |
TOI Health News Morning BriefingHere is the TOI health news morning briefing. Legal action against Serum Institute over Covid deaths. AstraZeneca admits side effects. India reports FLiRT COVID variants. 91 cases of the new Covid-19..IndiaTimes - Published | |
Kin claim deaths due to Covishield, to sue Serum Institute of IndiaParents sue Covishield maker over side-effects deaths, halted production due to reduced demand post high vaccination rates. Legal action in Supreme Court confirmed vaccine as the cause of deaths.IndiaTimes - Published | Covishield side effects disclosed in packaging: SIISerum Institute of India stopped Covishield production due to reduced demand post high vaccination rates. They disclosed rare side effects like Thrombosis with thrombocytopenia syndrome since 2021,..IndiaTimes - Published |
Stopped producing Covishield in Dec 2021: SII after AstraZeneca recallUK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped..IndiaTimes - Published | AstraZeneca withdraws COVID vaccine worldwideAstraZeneca withdraws COVID vaccine worldwide due to TTS. Facing 100 million pound lawsuit. TTS involves blood clots, low platelets. Symptoms: severe headache, abdominal pain. Treatment: anticoagulant..IndiaTimes - Published |
Sharad Pawar seeks Bharat Ratna for Dr PoonawallaFormer Union minister Sharad Pawar on Wednesday heaped praises on Dr Cyrus Poonawalla, founder of Serum Institute of India (SII), for his work in the field of vaccine production, and demanded that he..Mid-Day - Published | Meet woman, executive director of Rs 192000 crore company, known for glamorous and stylish lifeNatasha Poonawalla, who is enthusiastic about fashion and design. She is currently serving as the executive director of the Serum Institute of India (SII), one of the biggest producers of vaccines..DNA - Published |
Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is..He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic.DNA - Published | Adar Poonawala's mansion worth Rs 1446 croreFor those not aware of the name, Adar Poonawala is the CEO of Serum Institute of India, a company that achieved great success in vaccine making and distribution during the COVID pandemic.IndiaTimes - Published |
Imposition of tax on subsidies does not constitute 'taking away' of a benefit : Bombay HC; dismisses challenge by Serum InstituteThe Bombay High Court dismissed a petition filed by Serum Institute of India Pvt Ltd challenging a 2016 amendment to the Income Tax Act, 2015. The amendment included subsidies, grants, and incentives..IndiaTimes - Published | Meet man who owns exotic Rolls-Royce collection, cars worth over Rs 100 crore, not Mukesh Ambani, Ratan Tata, AdaniYohan Poonawalla is son of Zavaray Poonawalla who co-founded biopharmaceuticals firm Serum Institute of India along with his brother Cyrus Poonawalla in 1966. The billionaire also owns private..DNA - Published |
Meet Yohan Poonawalla, Adar Poonawalla's cousin, collector with cars worth over Rs 100 crore, bigger than Mukesh AmbaniYohan Poonawalla is the Chairman of Poonawalla Engineering Group and El-O- Matic India Pvt Ltd and he is also a shareholder in Serum Institute of India Pvt Ltd and Chairman of Poonawalla Financials Pvt..DNA - Published | Cyrus Poonawalla: The Son Of A Horse Breeder Who Didn't Follow His Family's Footsteps But Carved His Own Path And Now Has A Net Worth Of Rs 2,25,000 CroreCyrus Poonawalla founded the Serum Institute of India (SII) in 1966, which is today the world's largest vaccine manufacturer.Zee News - Published |
Age is just a number, look at Ratan Tata, Bachchan: NCP Lok Sabha member Supriya Sule takes on Ajit Pawar"Some people are saying that people who are senior now should give us their blessings (and retire). Why should they stop working? Ratan Tata who heads India's largest conglomerate is 86 years old...IndiaTimes - Published | This man leads India's most valuable unlisted company worth Rs 1.92 lakh crore, not Mukesh Ambani, Ratan Tata, AdaniAdar Poonawalla's Serum Institute of India (SII), which became a household name for developing Covid-19 vaccines, is ranked as India's most valuable unlisted company,DNA - Published |
Bombay HC says content posted against Covishield vaccine prima facie defamatoryThe Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..Mid-Day - Published | Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HCThe Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and..IndiaTimes - Published Also reported by •Mid-Day |
A New Beacon of Education - Utkal Gaurav International School Shines Bright in the Remote Village of Berunapadi, Odisha![]() NewsVoir - Published | Serum Institute to double investment in Biocon's unit to $300 millionIndiaTimes - Published |
Covovax for adults to reach metros in a week: SIISerum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..IndiaTimes - Published | DNA Explainer: What is R21/Matrix-M, Oxford-Serum Institute's 'world-changer' malaria vaccine?The R21 vaccine, created at Oxford University and approved by the Ghanaian Food and Drugs Authority, is now available to the age group most at risk of malaria-related mortality.DNA - Published |
SII to restart vaccine production amid surge in Covid casesSerum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus..IndiaTimes - Published | Serum Institute of India restarts manufacturing of Covid-19 vaccine CovishieldSerum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the..IndiaTimes - Published |
Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsIndiaTimes - Published Also reported by •Zee News | ET GrandMasters, an OTT Platform for Business Learning from Top Corporate Leaders of the Country![]() NewsVoir - Published |
Serum Institute to set up CoE for Infectious Diseases and Pandemic Preparedness in HyderabadnewKerala.com - Published | Serum Institute of India launches first made-in-India HPV vaccine for cervical cancernewKerala.com - Published |
DGCI approves market authorisation of Serum Institute's Covovax as booster dosenewKerala.com - Published | Drug panel favours nod for Covovax as Covid boosterAn expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..IndiaTimes - Published |
Covovax may get approval as heterologous boosterThe government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..IndiaTimes - Published | Covid situation in India better than elsewhere: SII CEO Adar PoonawallaSerum Institute CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying the government and the healthcare workers contributed largely to tackling the pandemic. "Everyone..IndiaTimes - Published |
Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar PoonawallaSerum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the..IndiaTimes - Published |